Home Tags COVID-19
COVID-19 could cause long-term neuron damage: Study
New research has shown that COVID-19 can fuse brain cells together, and could explain brain fog, headaches, loss of taste and smell and other long-term neurological symptoms some patients experience
Alnylam patent lawsuit against Pfizer, Moderna highlights escalating legal pressure on...
The potential for lucrative settlements in the multi-billion-dollar COVID-19 vaccine market adds further significance to these legal battles
Novavax AI approach to COVID-influenza vaccine design pays off in Phase...
Novavax’s trial design reflects a wider industry trend, as pharmaceutical companies are becoming highly active in utilizing AI technologies
Defeating Dengue: Experts highlight urgency on awareness, prevention & timely intervention
The experts also emphasized the criticality of managing dengue in individuals with comorbidities
Fresh insights into spread of airborne pathogens in indoor spaces
Researchers at the Indian Institute of Technology Delhi, in a study, have demonstrated the role of aerosol dispersion of SARS-Cov-2 virus and similar airborne pathogens in the spread of the disease in enclosed spaces
How are young Indians responding to climate change & COVID-19? Study...
The study found that although most people felt that they had the power to make a difference when it comes to climate change and COVID-19, this did not necessarily translate into action
India’s Evergreen Vaccine Story
India's biotechnology industry is positioned to become a significant engine of the Indian economy, writes Suchitra Ella, Managing Director, Bharat Biotech International Limited
Researchers devise field deployable alternative to RT-PCR
The newly developed ‘Recombinase Polymerase Amplification (RPA)’ method, wherein all the reactions take place close to room temperature, does not require a thermal cycler
“Innovations played a major role in India’s pandemic response”
Dr Taslimarif Saiyed, CEO and Director, Centre for Cellular and Molecular Platforms (C-CAMP), shares his thoughts on the India’s biotech R&D
Chinese regulators focus on homegrown COVID-19 therapies to tackle new variants,...
According to GlobalData’s Pharma Intelligence Center, there are currently 16 COVID-19 drugs in clinical development in China, five of which are in Phase III